États-Unis · Actualité générale · New York Post

Big, fat demand for weight-loss drugs fuels Eli Lilly stock surge — as market cap hits $1.2 trillion

Publié par New York Post · États-Unis il y a 1 h

Eli Lilly stock hit a record high Thursday thanks to a stronger-than-expected earnings report fueled by sales of weight loss drugs Monjuaro and Zepbound.

Lire l'article complet sur New York Post Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (nypost.com)

Big, fat demand for weight-loss drugs fuels Eli Lilly stock surge — as market cap hits $1.2 trillion

À lire aussi

Zambia’s edible insect tradition offers a potential boost to food security

CNN, MSNOW and Politico ask court to make Trump access order permanent

Vance undecided on whether Peltola should be prosecuted

Items found in Pompeii home hint at life before volcanic explosion

Barbara Barrie, Oscar-nominated actor, dies with medical assistance at 95

Charlie Kirk’s final endorsement is on the ropes — despite his group’s big push

Big, fat demand for weight-loss drugs fuels Eli Lilly stock surge — as market cap hits $1.2 trillion

Partager

À lire aussi

Zambia’s edible insect tradition offers a potential boost to food security

CNN, MSNOW and Politico ask court to make Trump access order permanent

Vance undecided on whether Peltola should be prosecuted

Items found in Pompeii home hint at life before volcanic explosion

Barbara Barrie, Oscar-nominated actor, dies with medical assistance at 95

Charlie Kirk’s final endorsement is on the ropes — despite his group’s big push